KLICKMER
Immudex ApS
Trademark Registered: 2022-05-24
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79311991 |
| Registration Number | 6720843 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2021-02-05 | Application Filed |
| 2021-05-27 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-05-27 | Status: Live/Pending |
| 2021-06-02 | Transaction Date |
| 2022-05-24 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Immudex ApS |
| Address | Bredevej 2A DK-2830 Virum XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Chemicals used in diagnostics, industry and science; diagnostic reagents for diagnostic (other than medical and veterinary) and scientific purposes; research reagents for scientific and diagnostic purposes; diagnostic test materials for scientific and diagnostic (other than medical and veterinary) purposes; diagnostic kits for scientific and diagnostic (other than medical and veterinary) purposes; assays for research and diagnostic (other than medical and veterinary) purposes; biochemical reagents (other than medical and veterinary); preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, including cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes |
| GS0051 | Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely, transplantation, immune monitoring, and vaccines and T-cell monitoring |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-05-27 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-06-02 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-06-08 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2021-08-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-08-31 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-09-01 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2021-09-13 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-09-13 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2021-10-04 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-01-13 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-01-13 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-01-13 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-01-20 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-02-02 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2022-02-02 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-02-02 | 16 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2022-02-20 | 17 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2022-02-22 | 18 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-02-22 | 19 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-05-10 | 20 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-05-24 | 21 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-08-24 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-09-09 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-09-09 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-10-03 | 25 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2023-04-02 | 26 NREP P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-04-14 | 27 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-04-14 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-04-14 | 29 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-04-14 | 30 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-04-14 | 31 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-04-14 | 32 CHAN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 